Literature DB >> 17963252

Mechanisms of iron loading and toxicity.

Gregory J Anderson1.   

Abstract

Normal iron homeostasis is a finely balanced system that reflects iron absorption, loss and utilization. The body has no mechanism for the active excretion of iron, so body iron levels are controlled at the point of absorption in the small intestine. Disturbances in this equilibrium, such as those leading to enhanced absorption, can have significant clinical consequences. Continued excessive iron uptake is followed by iron deposition in various tissues, ultimately leading to tissue damage, and possibly end-organ failure. In this review, current concepts in normal iron homeostasis, and iron loading are explained. The clinical consequences as well as the differences between primary and secondary iron loading are also reviewed, and some future research priorities are discussed. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963252     DOI: 10.1002/ajh.21075

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  26 in total

1.  Biocorrosion properties and blood and cell compatibility of pure iron as a biodegradable biomaterial.

Authors:  Erlin Zhang; Haiyan Chen; Feng Shen
Journal:  J Mater Sci Mater Med       Date:  2010-04-16       Impact factor: 3.896

Review 2.  Iron homeostasis and eye disease.

Authors:  Allison Loh; Majda Hadziahmetovic; Joshua L Dunaief
Journal:  Biochim Biophys Acta       Date:  2008-11-14

3.  Amyotrophic lateral sclerosis, enteral nutrition and the risk of iron overload.

Authors:  Alessio Molfino; Irma Kushta; Valentina Tommasi; Filippo Rossi Fanelli; Maurizio Muscaritoli
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

Review 4.  Early detection of cardiac involvement in thalassemia: From bench to bedside perspective.

Authors:  Nut Koonrungsesomboon; Siriporn C Chattipakorn; Suthat Fucharoen; Nipon Chattipakorn
Journal:  World J Cardiol       Date:  2013-08-26

5.  Significant Hyperbilirubinemia and Acute Hepatocellular Jaundice in a Pediatric Patient Receiving Deferasirox: A Case Report.

Authors:  Elizabeth A Feldman; Christopher D Miller; Sarabeth Wojnowicz; Robert Seabury
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Jan-Feb

6.  Polystyrene microsphere-ferritin conjugates: a robust phantom for correlation of relaxivity and size distribution.

Authors:  Preeti A Sukerkar; Uzma G Rezvi; Keith W Macrenaris; Pinal C Patel; John C Wood; Thomas J Meade
Journal:  Magn Reson Med       Date:  2010-10-28       Impact factor: 4.668

7.  Red blood cell transfusion independence following the initiation of iron chelation therapy in myelodysplastic syndrome.

Authors:  Maha A Badawi; Linda M Vickars; Jocelyn M Chase; Heather A Leitch
Journal:  Adv Hematol       Date:  2010-03-23

8.  Metabolic pathways related to oxidative stress in patients with hemoglobin h disease and iron overload.

Authors:  Shyh-Shin Chiou; Chao-Jung Tsao; Shih-Meng Tsai; Ye-Ru Wu; Yu-Mei Liao; Pei-Chin Lin; Li-Yu Tsai
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

9.  Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease.

Authors:  Nilesh R Ghugre; Ignacio Gonzalez-Gomez; Ellen Butensky; Leila Noetzli; Roland Fischer; Roger Williams; Paul Harmatz; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2009-08       Impact factor: 10.047

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.